Despite adequate medical management, dissection of the descending aorta (type B) may develop complications, including aneurysmal progression and eventually rupture. Partial false lumen thrombosis has been identified as a marker of adverse evolution in chronic dissection. The aim of this study was to test the ability of complementary information, provided by 
Introduction
Dissection of the aorta requires emergency care and specific therapy depending on individual pathology and vascular events portending an elevated risk of mortality. For acute type B dissections, medical management is initially advised in the attempt to transform the acute event into a more stable chronic scenario. 1 Chronic type B dissections, however, may be subject to ongoing false lumen expansion and eventual rupture. 2 Spontaneous changes of the false channel or the emergent use of Thoracic EndoVascular Repair (TEVAR) 3 may modify the natural course of chronic dissection by inducing complete thrombosis of the false lumen. In contrast, the reported risk associated with partial false lumen thrombosis 4, 5 should prompt the search for biomarkers able to predict adverse evolution of dissection in the chronic phase. Such biomarkers may be used to monitor the heterogeneous evolution of chronic aortic dissection and help understand the underlying pathophysiology. The primary aim of this study was to test whether initial and followup data, morphology of the false lumen, 18 F-FDG uptake in positron emission tomography/computed tomography (PET/CT), and plasma biomarkers of coagulation and fibrinolysis could signal secondary complications in a series of patients with chronic type B dissections. Although 18 F-FDG PET/CT imaging identifies the metabolic activity of the aortic wall component, plasma markers reflect the biological activity of thrombus formation and degradation over time within the false lumen.
Methods
The study was designed and conducted within the framework of the European programme 'Fighting Aneurysmal Disease (FAD)' after approval by the local ethics board of Liège University. During a 4-year period , patients with type B dissection, referred to the Department of Cardiovascular Surgery (University Hospital of Liège, Belgium) for surveillance of the disease, were invited to participate and give informed consent. Twenty-three eligible patients were included in the study during this period, excluding patients with Marfan syndrome. At enrolment, patients underwent an initial standard clinical examination, a PET/CT imaging procedure with injection of 18 F-FDG, and measurement of a panel of peripheral biomarkers of platelet activation, coagulation, fibrinolysis, polynuclear leucocyte activation, and heme-iron metabolism. Thereafter, patients were followed up and underwent repeated 18 F-FDG PET/CTs together with quantification of the same biomarkers. In December 2012, at least two sequential 18 F-FDG PET/CTs were available for all except two patients. Concomitant laboratory tests were missing for three PET/CTs, due to patients' refusal (n ¼ 2) and a technical problem (n ¼ 1), respectively. Throughout the study, therapeutic decisions, such as medical treatment and/or TEVAR, were based on the current clinical guidelines. The metabolic status of the dissected aortic wall assessed on PET/CT and the concentration of plasma biomarkers was known, but not pivotal in any individual decision-making process. More detailed information can be found in Supplementary data online. Secondary complications were defined as the observation of at least one of the following clinical events: a rapid increase in the aortic diameter of at least 10 mm/year, longitudinal progression of the dissection, aneurysmal dilation, refractory hypertension, persistent pain, extra-aortic bleeding, and visceral ischaemia. Aneurysm was defined as an expansion of the dissected aorta by at least 50% of the normal diameter during follow-up according to the joint councils of 'The Society for Vascular Surgery' and the 'North American Chapter of the International Society for Cardiovascular Surgery'. 6 The study was also designed to investigate whether 18 F-FDG PET/CT findings and plasma biomarker levels potentially correlated with aneurysmal progression. Any increased focal uptake, compared with the background, was recorded as positive (PET+) according to the visual analysis. The quantitative PET/CT assessment was described as maximum standardized uptake value (SUV max ), standardized uptake value in the liver (SUV liver ), and the SUV max-to-liver ratio (SUV RL ). The aortic diameter was measured and dilation was reported when total diameter was larger than that of the non-dissected upstream aorta. The biomarker panel included the following: plasma P-selectin, thrombin-antithrombin complexes (TAT), D-dimers, plasminantiplasmin complexes (PAP), myeloperoxidase (MPO), elastase, matrix metalloproteinease-9 (MMP-9), ferritin, and transferrin. All assays were expressed in ng/mL, except for D-dimers (mg/L).
Statistical analysis
Quantitative variables were summarized as means and standard deviation (SD), whereas frequency tables were used for categorical findings. Log transformation was applied to most biomarkers to normalize their distributions. Correlation coefficients were calculated to measure the association between two quantitative variables. To compare initial data in patients with and without secondary complications, the KruskalWallis test was used for mean values and the Fisher's exact test for proportions. Stepwise discriminant analysis was applied to assess the additive value of initial PET/CT to morphological data. The statistical analysis of longitudinal data collected from serial PET/CTs and biomarker assays in patients who developed an aneurysm and in those who did not was based on the general linear mixed model (GLMM). This method, accounting for time-related measurements within patients, was also applied to test for potential association of PET/CT characteristics and biomarker levels with false lumen morphology (patent, partial, or complete thrombosis) or between biomarkers. Results were considered significant at the 5% critical level (P , 0.05). Calculations were performed using SAS (version 9.3 for Windows) and S-PLUS (version 8.1) statistical packages.
Results

Initial data
Demographic and clinical characteristics of the 23 study patients are reported in Table 1 . There were 17 men and 6 women with a mean age of 62.3 + 11.5 years (range: 34 -78 years), 12 were past-smokers, and 5 current smokers (total 74%). The most frequent risk conditions were arterial hypertension (83%) and dyslipidaemia (57%). Eight (35%) patients had other aneurysmal diseases before dissection. Most patients were treated with aspirin (78%), statins (70%), and/ or beta-blockers (61%). Among the patients studied, 6 (26%) had been operated on for type A dissection of the ascending aorta before inclusion.
Morphology
Initially, the false lumen (CT scan) was found to be 'patent' for 10 patients, 'partially thrombosed' for 12 patients, and 'completely thrombosed' in 1 patient. The mean aortic diameter was 47.2 + 14.5 mm (range: 26-78 mm), and 15 (65%) patients had a dilated aorta ( Table 1) . While the aortic diameter was comparable in the three morphological groups (P ¼ 0.11), aortic dilation was more frequent in patients with partial false lumen thrombosis than in those with a patent or completely thrombosed false lumen (92 vs. 40% and 0%, respectively; Fisher's exact P ¼ 0.011).
F-FDG PET
Initially, there were 16 positive and 7 negative 18 F-FDG PET cases;
SUV max and SUV RL averaged 3.2 + 0.78 and 0.84 + 0.27, respectively ( Table 1 ). SUV max (P ¼ 0.029) and SUV RL (P ¼ 0.023) values were significantly higher in PET+ than in PET2 subjects. No association was found between false lumen morphology and initial PET positivity. The numbers of PET+ cases were 5 (50%), 10 (83%), and 1 (100%), respectively, in patent, partially thrombosed, and completely thrombosed false channels (Fisher's exact, P ¼ 0.23).
Circulating biomarkers
Initial concentrations of plasma biomarkers are reported in Table 1 .
None of the initial biomarker measurements was related to false lumen morphology at this time.
Follow-up data
During the 4-year study period, the mean follow-up time of the series was 16.7 + 8.0 months (range 3-35 months). In all, 55 combined 18 F-FDG uptake PET/CT images and 52 concomitant biomarker panel assays were performed on 23 patients. A total of 33 secondary complications were recorded during the follow-up in 17 (74%) patients. Their distribution is presented in Table 2 . As seen in Supplementary data online, Table S1 , the occurrence of complications was significantly higher in men than in women (88 vs. 33%, P ¼ 0.021) and in patients with arterial hypertension (84 vs. 25%, P ¼ 0.040). No difference was observed for other demographic and risk factors, or for medical treatment. Initial diameter of the dissected aorta significantly impacted the complication rate (P ¼ 0.0095) and the aortic dilation (P ¼ 0.0086). Table 3 reports that the initial false lumen morphology on CT was highly related to late complications (P ¼ 0.0046); 5 of 10 patients with a patent false lumen and all patients with partial thrombosis experienced complications, whereas the only patient with complete thrombosis remained free of any secondary (Figure 1) . The potential contribution of PET/ CT to morphological data with respect to secondary complications was confirmed by stepwise discriminant analysis (P ¼ 0.034). Our data showed that the initial diameter of the dissected aorta was significantly related to outcome (P ¼ 0.0095) as initial aortic expansion (P ¼ 0.0086). In contrast, none of the initial biomarker values were related to secondary complications (see Supplementary data online, Table S2 ).
Aneurysmal progression
During follow-up, the diameter of the dissected aorta remained unchanged in 5 of the 23 patients, increased by less than 10 mm/year in 13 patients, and by more than 10 mm/year in 5 patients. However, only 12 (52%) cases of aortic dilation progressed to aneurysm; eventually, 4 (25%) of these 12 patients underwent TEVAR in view of the increasing expansion of the false lumen and 1 (8%) because of extraaortic bleeding suggestive of consumptive coagulopathy ( Figure 2) . Interestingly, the male patient with the largest dissected expansion (78 mm, 80 years old) and enhanced local 18 F-FDG PET/CT uptake refused treatment and deceased a few months later with a retrograde type A dissection ( Figure 3 ).
Morphology and PET/CT
During follow-up, false lumen morphology changed from partial to complete thrombosis in one patient. When cross-classifying aneurysmal progression with the updated false lumen status, a highly significant association (P , 0.0001) was observed in relation to initial morphological data. As far as serial 18 F-FDG PET/CT examinations were concerned, GLMM analysis demonstrated that SUV max (P ¼ 0.0090) and SUV RL (P ¼ 0.0029) values observed during followup remained higher in the aneurysmal group than in patients without aneurysm ( Table 4 and see Supplementary data online, Figure S1 ).
Biomarkers
When considering peripheral plasma biomarker levels from the 52 blood samples collected during follow-up of the patients (Table 4 and see Supplementary data online, Figure S1 ), GLMM analysis showed, in a similar way, higher values of P-selectin (marker of platelet activation; P ¼ 0.0009) and of TAT complexes (markers of thrombin activation leading to fibrin formation; P ¼ 0.0075) in the group with aneurysmal expansion. D-dimers (P ¼ 0.0006) and PAP complexes (P , 0.0001) as circulating biomarkers of fibrinolytic activity also exhibited higher levels in this group. In contrast, plasma MMP-9 concentrations were lower in the aneurysmal group (P ¼ 0.014). No differences were observed for other biomarkers, indicating their lack of relationship to aneurysmal expansion.
Biology and morphology
Thrombus formation is always associated with ongoing fibrinolytic activity that can be monitored by measuring platelet and thrombin activation on the one hand and plasmin activation and fibrin degradation on the other. 8 Therefore, biomarker levels during follow-up were also analysed according to false lumen status of the patients (Supplementary data online, Table S3 ). GLMM analyses showed that plasma levels of P-selectin, TAT complexes, D-dimers, and PAP complexes were markedly higher in patients with a partially thrombosed false lumen compared with those with a patent or completely thrombosed one. MMP-9 levels were lower in patients with a partial and complete thrombosis than in patent patients; no differences were observed for MPO, elastase, ferritin, or transferrin levels.
Biology, PET/CT imaging, and aortic diameter
To assess the interactions between 18 F-FDG uptake and aortic wall, plasma biomarker levels, and aortic diameter in type B dissections, correlations between all parameters were calculated over the entire follow-up period and tested by GLMM analysis to account for within-subject variability resulting from subsequent examinations (see Supplementary data online, Table S4 ). Biomarkers of coagulation and fibrinolysis (P-selectin, TAT, D-dimers, and PAP) were dependent on each other (r-values: 0.34-0.70, all P , 0.05); likewise, among markers of neutrophil activation, elastase was positively correlated with MMP-9 (r ¼ 0.37) and MPO (r ¼ 0.41). Significant correlations were also found between elastase and P-selectin (r ¼ 0.37), PAP (r ¼ 0.31) and D-dimers (r ¼ 0.41), respectively, but not with TAT. Interestingly, SUV max was inversely related to plasma transferrin (r ¼ 20.30, P ¼ 0.032), but unrelated to markers of coagulation, fibrinolysis, or neutrophil activation. In contrast, SUV RL values increased with PAP (r ¼ 0.31, P ¼ 0.035), decreased with plasma transferrin (r ¼ 20.42, P ¼ 0.0026), but remained unchanged for ferritin (P ¼ 0.46). Importantly, aortic diameter measurements recorded during follow-up correlated strongly with D-dimers, SUV max , and SUV RL (all P , 0.001) and to a lesser extent with P-selectin and PAP. 
Vascular metabolic imaging and peripheral plasma biomarkers
Discussion
The present study on 23 patients with chronic type B dissections of the aorta provides, despite its limited sample size, new insights into the mechanism leading to secondary complications and, possibly, to fatal aortic rupture. It confirms the high prognostic value of partial false lumen thrombosis, whereas a patent or completely thrombosed false lumen was generally associated with stability and better outcome. 9 -12 Our observations support the hypothesis generated by previous findings 4, 5, 7 that partial thrombosis of the false channel, involving permanent renewal of the thrombus within the false lumen, by low-sheared recirculating blood, and the corresponding fibrinolysis, impact evolution of type B dissections. In our study, type B dissections with a patent false lumen revealed a higher risk of secondary complications when associated with enhanced wall 18 F-FDG uptake (PET/CT+). To our knowledge, this is the first report in which metabolic imaging of the aortic wall is independently associated with poor outcome of chronic dissection of the aorta, as a complement to false lumen morphology. When considering aneurysmal expansion, the present study demonstrated a relation between 18 F-FDG PET/CT findings, false lumen morphology, and concomitant plasma biomarker levels recorded serially during follow-up of the patients. The localized PET signal of enhanced 18 F-FDG uptake in the wall of dissected aorta and concomitantly increased biomarkers of coagulation and fibrinolysis were signs of aneurysmal expansion. Enhanced 18 F-FDG uptake correlated with the presence of inflammatory cells in the adventitia of abdominal aortic aneurysm, 13, 14 which is in part influenced by the biological turnover of the intraluminal thrombus (ILT). 15 -17 In arterial segments with ILT and enhanced 18 F-FDG uptake, 18 the adventitia is richer in leucocytes, 19 consisting of phagocytes, endocytosing heme-iron from the haemoglobin-rich ILT, and lymphocyte-rich granuloma, all with high metabolic turnover. 17 Relative 18 F-FDG uptake (SUV RL ) in the arterial wall correlated inversely with plasma transferrin, the transporter involved in iron recycling, and was associated with plasma P-selectin and TAT, suggesting a relationship between 18 F-FDG uptake and localized iron metabolism in the arterial wall, and similar links to platelet and thrombus formation. Neutrophil activation was not associated with detrimental evolution, suggesting that fibrinolysis is a more important prognostic determinant than neutrophil activation. These novel findings may impact the management of chronic type B dissections. Indeed, while only late expansion beyond a critical diameter was considered predictive of eventual rupture in the setting of asymptomatic chronic dissection, local metabolic activity and elevated biomarkers may now better reflect individual risk than aortic dimensions alone.
Earlier observations on high 18 F -FDG uptake in dissected aortic wall, associated with an increased risk for rupture and progression, have failed to explain the underlying mechanism. 20 Our observation of consumptive coagulopathy, however, sheds light on the mechanism of how the false lumen thrombus, along with platelet and fibrinogen consumption, is associated with high fibrinolytic activity, hence resulting in high biological thrombus turnover in the false lumen. Thus, aneurysmal progression, enhanced 18 F-FDG uptake in the dissected aortic wall, and circulating markers of coagulopathy interact. Several cases have been published on consumptive coagulopathy and peripheral bleeding in association with progressive dissections, 21, 22 including clinical (cessation of bleedings) and biological normalization after successful endovascular grafting. 23 Besides the potential use of 18 F-FDG uptake and thrombus morphology as early prognostic tools, the impact of endovascular stent-graft placement in patients with enhanced aortic wall metabolism supports the preceding hypothesis. In asymptomatic type B dissections, stentgrafting did not improve early survival beyond 2 years, but with the induction of complete thrombosis and remodelling, TEVAR provided long-term stability of dissected aorta and better survival after 5 years. 3, 24 As in the INSTEAD-XL study, 24 late aortic ruptures did not occur in the present series. With conversion from partial to complete false lumen thrombosis, the complete isolation of the false lumen from residual perfusion may suppress both thrombus bioactive turnover, and allow structural healing, fibrosis, and successful remodelling. 25 -28 Therefore, 18 F -FDG uptake associated with Vascular metabolic imaging and peripheral plasma biomarkers plasma biomarkers of coagulation and fibrinolysis could be instrumental in selecting patients for TEVAR with chronic dissection regardless of diameter or symptoms.
The present study suffers a number of limitations. With type B dissection being a rare disease, the number of patients included in the study was limited. Therefore, although statistically significant, most findings should be considered with caution and the conclusions require confirmation on larger cohorts. Despite a study duration of over 4 years, the mean follow-up time of the patients was short. The use of 18 F-FDG uptake for analysing arterial wall pathology is limited by two methodological aspects regarding the biological specificity of 18 F-FDG uptake and the spatial resolution of extracorporeal positron recording, respectively. 18 F-FDG uptake explores the glucose transporter-dependent bioenergetic pathway within the tissue, but does not take into account other energetic pathways. Nevertheless, macrophage polarization is not associated with increasing glucose harnessing. 29 Therefore the exact biological activity measured by 18 F-FDG uptake in the arterial wall remains elusive. In parallel, the recorded positron signal intensity is spatially diluted, due to the partial volume effect 30, 31 with regard to the arterial wall thinness, leading to a loss of sensitivity in SUV max . Finally, another prospective study in acute aortic diseases failed to observe significant differences in D-dimers or CRP levels between positive 18 F-FDG and negative 18 F-FDG uptake at the dissection level. 32 In conclusion, the present translational clinical investigation demonstrated that enhanced 18 F-FDG uptake in the aortic wall contributes to the prognostic value of false lumen morphology in predicting secondary complications in patients with type B dissections. Moreover, it has also highlighted the importance of markers of thrombus biological turnover as signals of silent progressive expansion in the dissected aorta. Better characterization by functional imaging of patients with type B dissection may be instrumental to improve the selection of patients for specific therapies in the chronic phase of dissection.
Supplementary data
Supplementary data are available at European Heart JournalCardiovascular Imaging online. For comparing the evolutions in the two groups, P-values were obtained from the GLMM, which accounts for serial values within patients.
